Mitochondrial Role in Oncogenesis and Potential Chemotherapeutic Strategy of Mitochondrial Infusion in Breast Cancer

Area of Science:

• Oncology
• Cell Biology
• Metabolic Research

Background:

• Triple negative breast cancer (TNBC) is an aggressive malignancy with poor prognosis and high treatment failure rates.
• Mitochondria play crucial roles in cancer development through altered metabolism, reactive oxygen species (ROS) generation, and apoptosis evasion.
• Mitochondrial dysregulation is a hallmark of many cancers, including TNBC.

Purpose of the Study:

• To review the role of mitochondrial dysregulation in cancer, particularly TNBC.
• To explore the potential of mitochondrial infusion as an anti-cancer therapeutic strategy.
• To highlight how mitochondrial-mediated mechanisms can be leveraged for cancer treatment.

Main Methods:

• Literature review of in vitro and in vivo studies.
• Analysis of research on mitochondrial function in cancer biology.
• Synthesis of data on mitochondrial infusion therapies and their effects.

Main Results:

• Mitochondrial infusion can reduce cancer cell glycolysis and enhance oxidative phosphorylation (OXPHOS).
• Therapeutic mitochondrial interventions demonstrate reduced cancer cell proliferation.
• Mitochondrial-based treatments show potential for enhancing apoptosis in cancer cells.

Conclusions:

• Mitochondrial infusion represents a promising therapeutic avenue for aggressive cancers like TNBC.
• Targeting mitochondrial pathways offers a novel strategy to overcome treatment resistance in TNBC.
• Restoring normal mitochondrial function holds potential for effective cancer treatment.